S 1094
107th Congress
Senate
Health
Blood diseases
Cancer
Cancer research
Department of Health and Human Services
Economics and Public Finance
Federal aid to medical research
Government Operations and Politics
Government publicity
Health education
Leukemia
Research centers
Science, Technology, Communications
Hematological Cancer Research Investment and Education Act of 2002
Introduced: June 22, 2001
See on congress.gov
Everywhere this bill has been
23 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 14, 2002
Became Public Law No: 107-172.
May 14, 2002
Signed by President.
May 6, 2002
Presented to President.
Apr 30, 2002
Motion to reconsider laid on the table Agreed to without objection.
Apr 30, 2002
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H1722-1723)
Apr 30, 2002
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H1722-1723)
Apr 30, 2002
DEBATE - The House proceeded with forty minutes of debate on S. 1094.
Apr 30, 2002
Considered under suspension of the rules. (consideration: CR H1722-1725)
Apr 30, 2002
Mr. Bilirakis moved to suspend the rules and pass the bill.
Nov 28, 2001
Referred to the Subcommittee on Health.
Nov 19, 2001
Referred to the House Committee on Energy and Commerce.
Nov 19, 2001
Received in the House.
Nov 19, 2001
Message on Senate action sent to the House.
Nov 16, 2001
Passed Senate with an amendment by Unanimous Consent. (text: CR S12015-12016)
Nov 16, 2001
Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.(text: CR S12015-12016)
Nov 16, 2001
The committee substitute agreed to by Unanimous Consent.
Nov 16, 2001
Measure laid before Senate. (consideration: CR S12015-12016; text of measure as reported in Senate: CR S12015)
Nov 8, 2001
Placed on Senate Legislative Calendar under General Orders. Calendar No. 221.
Nov 8, 2001
Committee on Health, Education, Labor, and Pensions. Reported by Senator Kennedy with an amendment in the nature of a substitute. Without written report.
Nov 1, 2001
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Jun 22, 2001
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S6669-6670)
Jun 22, 2001
Sponsor introductory remarks on measure. (CR S6669)
Jun 22, 2001
Introduced in Senate
Plain-English summary
Hematological Cancer Research Investment and Education Act of 2001 - Amends the Public Health Service Act to require: (1) the Director of the National Institutes of Health to establish a blood cancer research, information, and education program, particularly with respect to leukemia, lymphoma, and multiple myeloma; and (2) the Director of the Centers for Disease Control and Prevention to establish a related public information program.
What's happening now
Became Public Law No: 107-172.
Committees of jurisdiction
3
Cosponsors
1